AIG
NGNE icon

American International Group’s Neurogene NGNE Stock Holding History

American International Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-874
Closed -$33K – 3208
2022
Q1 		$33K Sell
874
-62
-7% -$3.62K ﹤0.01% 2958
2021
Q4 		$90K Sell
936
-28
-3% -$3.41K ﹤0.01% 2760
2021
Q3 		$139K Sell
964
-22
-2% -$3.37K ﹤0.01% 2642
2021
Q2 		$182 Buy
986
+47
+5% +$10.4K ﹤0.01% 2561
2021
Q1 		$231 Buy
939
+3
+0.3% +$767 ﹤0.01% 2291
2020
Q4 		$264 Sell
936
-27
-3% -$6.6K ﹤0.01% 2130
2020
Q3 		$231K Buy
963
+55
+6% +$13.3K ﹤0.01% 2055
2020
Q2 		$301K Buy
+908
New +$237K ﹤0.01% 1876

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American International Group's NGNE Position: Q2 2022 in Review

American International Group sold out of Neurogene (NGNE) in Q2 2022, closing a stake of 874 shares — an estimated $33K sold.

American International Group first reported a position in NGNE in Q2 2020 and held it in 8 quarters. The position peaked at $301K in Q2 2020. 63 funds tracked by Wall St. Rank hold NGNE as of Q2 2022.

  • American International Group reported no remaining Neurogene position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 874 Neurogene shares in Q2 2022, an estimated $33K.
  • American International Group first reported a position in Neurogene in Q2 2020 and held it in 8 quarters.
  • American International Group's Neurogene position peaked at $301K in Q2 2020.
  • 63 funds tracked by Wall St. Rank held Neurogene as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.